Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Assets (2020 - 2025)

Historic Assets for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • Ensysce Biosciences' Assets fell 6612.09% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 6612.09%. This contributed to the annual value of $5.6 million for FY2024, which is 10668.6% up from last year.
  • Latest data reveals that Ensysce Biosciences reported Assets of $3.2 million as of Q3 2025, which was down 6612.09% from $5.6 million recorded in Q2 2025.
  • Ensysce Biosciences' Assets' 5-year high stood at $16.4 million during Q4 2021, with a 5-year trough of $2.7 million in Q4 2023.
  • Moreover, its 5-year median value for Assets was $5.7 million (2022), whereas its average is $6.9 million.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 456657.83% in 2021, then tumbled by 6835.58% in 2023.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Assets stood at $16.4 million in 2021, then crashed by 64.15% to $5.9 million in 2022, then tumbled by 53.98% to $2.7 million in 2023, then skyrocketed by 106.69% to $5.6 million in 2024, then crashed by 43.2% to $3.2 million in 2025.
  • Its Assets was $3.2 million in Q3 2025, compared to $5.6 million in Q2 2025 and $4.6 million in Q1 2025.